Answers are grounded in this paper and cite their sources.
The assessment and management of totally implanted vascular access devices (TIVAD) prior to the administration of medications/fluids are vital to ensuring the risk of harm is mitigated. While numerous guidelines exist for the insertion and management of TIVAD, the level of evidence and external validity to support these guidelines is lacking.
No takes yet. Share an insight, caveat, or question.
Meredith et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: